Whitepaper: Biochip array technology – an effective and reliable multi-analytical tool
1 September 2016 • Author(s): Randox Food Diagnostics
Multiplex screening of a broad range of drug residues from a single sample over a range of matrices with a single analytical platform.
Biochip Array Technology
Biochip Array Technology (BAT) provides a platform for the simultaneous determination of multiple drug residues from a single sample using miniaturized immunoassays with implications in the reduction of sample/reagent consumption and an increase in the output of test results.1,2
The biochip: the core of the technology
The core of the system is the biochip (9mm x 9mm) and represents the platform in which the capture molecules are immobilized and stabilised in pre-defined x,y coordinates defining arrays of discrete test regions (DTRs) on a pre-activated surface (Figure 1). Up to 25 tests can be carried out per biochip. The biochip is also the vessel where simultaneous chemiluminescent immunoreactions take place. The biochips are supplied in carriers containing 3 x 3 biochips, which is equivalent to nine reaction wells per carrier, where samples and reagents are added. A carrier handling tray is provided with the system, which allows the simultaneous handling of six carriers (54 biochips).
ABF Ingredients ANDEROL EUROPE BV Avantes Berndorf Band GmbH BIOTECON Diagnostics GmbH Cargo Oil AB Elea GmbH Engilico FUCHS LUBRITECH GmbH GLOBALG.A.P. Foodplus GmbH InS Services (UK) Ltd IONICON Analytik GmbH JAX INC. JBT Corporation LUBRIPLATE Lubricants Company NSF International Ocean Optics PCE Instruments UK Ltd R-Biopharm Rhone Ltd Stancold SteriBeam The Tintometer® Group Thermo Fisher Scientific TOMRA Sorting Food Uhde High Pressure Technologies GmbH Verner Wheelock Vikan UK Ltd